Literature DB >> 16228279

Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.

R G Arther1, D D Bowman2, R L Slone3, L E Travis4.   

Abstract

A topically applied formulation containing 10% imidacloprid+2.5% moxidectin (Advocate/Advantage multi) has been developed for monthly application to dogs for the prevention of canine heartworm (HW) disease caused by Dirofilaria immitis; and for the treatment and control of flea infestations, mite infestations, and intestinal nematode infections. The efficacy of this formulation to prevent canine HW disease was confirmed at three study locations which included the use of 88 purpose-bred beagles 6-8 months of age. Two of these studies also evaluated the effects of post-treatment water exposure or shampooing on product performance. Each dog was infected with 50 third-stage D. immitis larvae on test days -30 to -45. Dogs were blocked according to gender and body weight on test day -1. Topically applied test articles were administered once on test day 0 as follows: 10% imidacloprid+2.5% moxidectin (52 dogs); 2.5% moxidectin mono solution (eight dogs); 10% imidacloprid mono solution (16 dogs); and placebo solution (12 dogs). Treatment dosages were applied to provide a minimum of 10 mg/kg imidacloprid and/or 2.5 mg/kg moxidectin. Subgroups of dogs were exposed to water to simulate swimming/rain exposure at designated post-treatment intervals. Additional dogs were shampooed at 90 min, 4 h, or 24 h post-treatment. All dogs were necropsied 110-119 days post-treatment for recovery of adult D. immitis. No adult D. immitis were recovered at necropsy from any of the dogs receiving 10% imidacloprid+2.5% moxidectin or 2.5% moxidectin mono solution, demonstrating 100% efficacy for prevention of D. immitis infection. A total of 701 adult D. immitis were recovered at necropsy from dogs receiving 10% imidacloprid mono solution or placebo (range of 11-40 D. immitis/dog). The efficacy of 10% imidacloprid+2.5% moxidectin treatment for the prevention of HW disease was not decreased when dogs were shampooed as early as 90 min post-treatment, or when dogs immersed in water 5 times post-treatment at weekly intervals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16228279     DOI: 10.1007/s00436-005-1448-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  9 in total

Review 1.  Insect nicotinic acetylcholine receptor agonists as flea adulticides in small animals.

Authors:  D T Vo; W H Hsu; E A Abu-Basha; R J Martin
Journal:  J Vet Pharmacol Ther       Date:  2010-08       Impact factor: 1.786

2.  Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.

Authors:  Dwight D Bowman; Samuel D Charles; Robert G Arther; Terry Settje
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

3.  Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.

Authors:  Klaus Hellmann; Josef Heine; Gabriele Braun; Radmila Paran-Dobesova; Vlasta Svobodova
Journal:  Parasitol Res       Date:  2011-08       Impact factor: 2.289

4.  Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate, Bayer) spot-on.

Authors:  Eva Fok; Olga Jacsó; Zsolt Szebeni; András Gyorffy; László Sükösd; Zoltán Lukács; Roland Schaper
Journal:  Parasitol Res       Date:  2010-02-18       Impact factor: 2.289

5.  Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.

Authors:  Tom L McTier; Robert H Six; Aleah Pullins; Sara Chapin; Kristina Kryda; Sean P Mahabir; Debra J Woods; Steven J Maeder
Journal:  Parasit Vectors       Date:  2019-09-11       Impact factor: 3.876

6.  Cross-reactions of sera from dogs infected with Angiostrongylus vasorum in commercially available Dirofilaria immitis test kits.

Authors:  Manuela Schnyder; Peter Deplazes
Journal:  Parasit Vectors       Date:  2012-11-13       Impact factor: 3.876

Review 7.  Treatment of MDR1 mutant dogs with macrocyclic lactones.

Authors:  Joachim Geyer; Christina Janko
Journal:  Curr Pharm Biotechnol       Date:  2012-05       Impact factor: 2.837

8.  Development of advantus(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs.

Authors:  Tariq Qureshi; William R Everett; Kathleen G Palma
Journal:  Parasit Vectors       Date:  2015-08-04       Impact factor: 3.876

9.  Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.

Authors:  Byron L Blagburn; Robert G Arther; Allen R Dillon; Jamie M Butler; Joy V Bowles; Cristiano von Simson; Robert Zolynas
Journal:  Parasit Vectors       Date:  2016-04-05       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.